Cytognos S.L. Revenue and Competitors

Cytognos S.L. is a biotechnology company dedicated to the design and development of new reagents, software and techniques to provide innovative solutions in flow cytometry. Since 1996 we offer solutions in the diagnosis and monitoring of hematologic diseases by flow cytometry Cytognos markets a large number of antibodies directed against human antigens, isotype controls and single, double and triple reagents to study cell cycle and DNA content (multiple myeloma, Cell Acute Lymphoblastic Leukemia B-Cell Non-Hodgkin B, Screening for Bladder Cancer), multicolor kits for studying lymphocyte subpopulations, MRD monitoring and screening of multiple myeloma, BCP-ALL, paroxysmal nocturnal hemoglobinuria... We have also developed systems of absolute cell count and erythrocyte lysing solution Quicklysis. Infinicyt? is the most porwerful software for the analysis of flow cytometry data, it was sponsored by the EC under the Sixth Framework Programme. Areas of interest for future collaborations: Cytognos is always open to possible collaborations, both in the development of new joint projects, as in the commercial exploitation of new methods. The main areas of interest are those related to Oncology, Immunology and Hematology.